Results 81 to 90 of about 35,181 (254)

The binding of botulinum neurotoxins to different peripheral neurons [PDF]

open access: yes, 2017
Botulinum neurotoxins are the most potent toxins known. The double receptor binding modality represents one of the most significant properties of botulinum neurotoxins and largely accounts for their incredible potency and lethality.
Rossetto, O.
core   +1 more source

Overactive bladder

open access: yesJournal of Education, Health and Sport, 2021
Urinary incontinence is a problem among both older and young women. The most common symptoms of this condition include urinary incontinence and an unpleasant odour. In order to conceal the ailments related to this problem, women change their lifestyle by limiting the amount of fluid consumed and not moving too far from home or places where toilets are ...
openaire   +2 more sources

Phenotyping Overactive Bladder—Part 1: Are There Different Types of Urgency and Can They be Translated to Clinical, Urodynamic and Radiological Phenotyping? ICI‐RS 2025

open access: yesNeurourology and Urodynamics, EarlyView.
ABSTRACT Introduction Overactive bladder (OAB) is defined as urinary urgency, usually accompanied by increased daytime frequency and/or nocturia, with urgency urinary incontinence (OAB‐wet) or without (OAB‐dry), in the absence of urinary tract infection or other detectable disease.
John E. Speich   +9 more
wiley   +1 more source

Overactive bladder – 18 years – part I

open access: yesInternational Brazilian Journal of Urology, 2016
Abstract: Overactive bladder syndrome is one of the lower urinary tract dysfunctions with the highest number of scientific publications over the past two decades.
Jose Carlos Truzzi   +26 more
doaj   +1 more source

An animal experimental study on pubourethral ligament restoration with platelet rich plasma for the treatment of stress urinary incontinence. [PDF]

open access: yes, 2019
Introduction: Minimally invasive methods for injured ligament and tendon restoration have been developed and gained popularity in recent years. Injury and relaxation of the pubourethral ligament (PUL) can lead to stress urinary incontinence (SUI).
Chrysanthopoulou, E   +6 more
core   +1 more source

Impact of COVID‐19 and Vaccination on Lower Urinary Tract Symptoms: Insights From a Prospective Cohort Study

open access: yesNeurourology and Urodynamics, EarlyView.
ABSTRACT Aims To evaluate the prevalence, clinical course, and risk factors of lower urinary tract symptoms (LUTS) in patients hospitalized with COVID‐19, and to assess associations with comorbidities, disease severity, and vaccination status. Methods We conducted a prospective cohort study of adult patients hospitalized with confirmed COVID‐19, who ...
Julia Duarte de Souza   +12 more
wiley   +1 more source

Nerve growth factor level in urine: opportunitiesa new diagnostic test in women with overactive bladder (findings)

open access: yesГинекология, 2013
The reasons that cause the symptoms of overactive bladder, it is extremely diverse, so it is very important the correct diagnosis. Can the definition of nerve growth factor in the urine samples to be objective method of diagnosis of overactive bladder ...
F N Mahmedjanova, I A Apolikhina
doaj  

An examination of Overactive Bladder Syndrome: present comprehension, methods of treatment, and innovative approaches

open access: yesJournal of Education, Health and Sport
Introduction Overactive bladder syndrome poses a major challenge to healthcare, as an accurate estimate of its prevalence proves elusive due to patients' reluctance to disclose the embarrassing symptoms that accompany the disorder.
Zuzanna Kotowicz   +2 more
doaj   +1 more source

Clinical use of the beta-3 adrenoceptor agonist mirabegron in patients with overactive bladder syndrome [PDF]

open access: yes, 2015
Mirabegron is a β 3 adrenoceptor agonist licensed for the treatment of overactive bladder symptoms, such as urinary urgency or urgency incontinence. β 3 adrenoceptor activation causes detrusor muscle relaxation, but mirabegron may also act by binding ...
Drake, Marcus, Vij, Monika
core   +2 more sources

“What Medical Management Should Be First Line for Bladder Storage Symptoms in NLUTD”—Pro Botox

open access: yesNeurourology and Urodynamics, EarlyView.
ABSTRACT Objectives Neurogenic lower urinary tract dysfunction (NLUTD) severely impairs patient quality of life (QoL). While oral medications are often first‐line treatments, their high failure rates and side effects limit their effectiveness. Thus, we argue for the use of intravesical botulinum toxin A (BoNT‐A) injections as a first‐line alternative ...
Vada Furlan   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy